Rouan Awarded Mastership by the American College of Physicians
Gregory Rouan, MD, chair of the Department of Internal Medicine in the University of Cincinnati (UC) College of Medicine, has been awarded Mastership by the American College of Physicians (ACP), the national organization of internists.
Rouan, the Gordon and Helen Hughes Taylor Professor of Medicine at UC, has been an ACP fellow since 1988 and active in regional and national committees of the ACP. He has served as treasurer for the Ohio Chapter of the ACP and the ACP Governor of the Ohio Chapter. Rouan is also president of the Cincinnati Society of Internal Medicine and president of the Cincinnati Academy of Medicine. He is a member of the board of directors for UC Health.
Election to Mastership recognizes outstanding extraordinary career accomplishments. Masters must have made a notable contribution to medicine. This includes, but is not limited to teaching, outstanding work in clinical medicine, contributions to preventive medicine, improvements in the delivery of health care, and/or contributions to the medical literature.
According to ACP bylaws, Masters are elected "on account of personal character, positions of honor, contributions toward furthering the purposed of the ACP, eminence in practice or in medical research, or other attainments in science or in the art of medicine. ACP activities are also taken into consideration for all candidates. This includes service to the ACP in an official capacity, participation in chapter activities, and involvement in the development of ACP products and educational programs. Volunteer and community service is also taken into consideration.
Rouan and others offer Masters were honored at the annual convocation ceremony during Internal Medicine Meeting 2018, ACPs annual scientific conference, held April 19-21, 2018, in New Orleans.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.